Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
SUPN
$48.27
+2.38%
SUPN · Supernus Pharmaceuticals, Inc.
$48.27
+1.12 (+2.38%)
At close · Aug 14
Market Cap
$2.81B
Shares
58.13M
All earnings calls
Earnings call · FY2023 Q3
Supernus Pharmaceuticals, Inc. Q3 FY2023 Earnings Call
Supernus Pharmaceuticals, Inc. Q3 FY2023 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$153.88M
-13.2% YoY
Diluted EPS
-$0.29
-1066.7% YoY
Net income
-$15.98M
-1013.4% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Oct 25, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 8, 2023 · complete as-filed document